Can AI Really Speed Up the Path to New Medicines?
AI integrates deeply into biomedical research, streamlining drug design and genomic insights while addressing data biases for equitable health outcomes. Leading firms like Insilico and Tempus pioneer tools that cut development times and personalize care.
